Is there a common mechanism of benefit for effective treatment of heart failure?

[1]  K. Adams,et al.  Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators. , 1996, Circulation.

[2]  J. Cohn,et al.  The management of chronic heart failure. , 1996, The New England journal of medicine.

[3]  M. Radford,et al.  Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure. CHF-STAT Investigators. , 1996, Circulation.

[4]  P. Poole‐Wilson.  Spirals, paradigms, and the progression of heart failure. , 1996, Journal of cardiac failure.

[5]  C. T. Layton,et al.  Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia , 1996 .

[6]  P C Deedwania,et al.  Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. , 1995, The New England journal of medicine.

[7]  J. Cohn.  Structural basis for heart failure. Ventricular remodeling and its pharmacological inhibition. , 1995, Circulation.

[8]  J. Cohn,et al.  Prognostic Significance of Serial Changes in Left Ventricular Ejection Fraction in Patients With Congestive Heart Failure , 1993, Circulation.

[9]  J. Cohn,et al.  Enalapril Decreases Prevalence of Ventricular Tachycardia in Patients With Chronic Congestive Heart Failure , 1993, Circulation.

[10]  J. Cohn,et al.  Plasma Norepinephrine, Plasma Renin Activity, and Congestive Heart Failure Relations to Survival and the Effects of Therapy in V‐HeFT II , 1993, Circulation.

[11]  F. Tristani,et al.  Ejection Fraction, Peak Exercise Oxygen Consumption, Cardiothoracic Ratio, Ventricular Arrhythmias, and Plasma Norepinephrine as Determinants of Prognosis in Heart Failure , 1993, Circulation.

[12]  J. Cohn,et al.  Mechanism of Death in Heart Failure The Vasodilator‐Heart Failure Trials , 1993, Circulation.

[13]  P. Binkley,et al.  Plasma Endothelin Correlates With the Extent of Pulmonary Hypertension in Patients With Chronic Congestive Heart Failure , 1992, Circulation.

[14]  F. Tristani,et al.  A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. , 1991, The New England journal of medicine.

[15]  J. Cohn,et al.  Heart failure with normal ejection fraction. The V-HeFT study , 1990 .

[16]  M. Weir,et al.  The Cardiac Arrhythmia Suppression Trial Investigators: Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression After Myocardial Infarction. , 1990 .

[17]  W. Rogers,et al.  Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. , 1989, The New England journal of medicine.

[18]  F. Tristani,et al.  Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure. Results of a Veterans Administration Cooperative Study , 1987 .

[19]  F. Tristani,et al.  Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure , 1986 .

[20]  G. Reeder,et al.  Atrial natriuretic peptide elevation in congestive heart failure in the human. , 1986, Science.

[21]  J. Cohn,et al.  Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. , 1984, The New England journal of medicine.

[22]  P. Kudenchuk,et al.  Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias. , 1983, Journal of the American College of Cardiology.

[23]  J. Cohn,et al.  Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. , 1982, The American journal of cardiology.